Genetic markers play a crucial role in identifying crop types, especially in sample types unsuitable for chemical analysis (e.g., trace residues, small leaf fragments, immature crops). Cannabinoid synthase genes are key enzymes in determining a crop’s chemical composition or chemotype. However, existing markers often overlook the analysis of pseudogenes in the cannabis genome. Cannabinoid synthase genes are found to be highly repetitive in the cannabis genome and contain many incomplete coding sequences (pseudogenes) that can have 91–95% nucleotide identity to functional synthase genes. The risk of amplification of pseudogenes needs to be carefully evaluated in all synthase-gene targeting methods for genetic testing of cannabis. To address this, we previously developed a custom NGS panel targeting all synthase genes (THCAS, CBDAS, and CBCAS) as well as their pseudogenes. To ensure a comprehensive analysis, a diverse array of sample types was incorporated. These samples included reference C. sativa samples sourced from the National Institute on Drug Abuse (NIDA) and the National Institute of Standards and Technology (NIST), along with CBD, CBG, delta-8-THC, delta-10-THC, THCO, and CBDV hemp samples containing. Additionally, the study included hemp seed samples and extracts from seized marijuana provided by the Drug Enforcement Agency (DEA). The identified novel polymorphisms were then incorporated into two fast genotyping assays. The study developed a SNaPshot™ assay and a TaqMan™ quantitative Polymerase Chain Reaction (qPCR) Single Nucleotide Polymorphism (SNP) genotyping assay for hemp-marijuana differentiation. SNaPshot™, with four markers on the THCAS gene, THCAS pseudogene, and CBDAS gene successfully differentiated five hemp types and hemp seeds from seized marijuana across various locations in the United States, Chile, and the Mexico-United States border. Furthermore, this assay yielded valuable CBD information in the marijuana samples. On the other hand, the TaqMan™ qPCR SNP genotyping assays, using two markers on the THCAS gene and THCAS pseudogene, showed efficient differentiation of the majority of hemp samples from marijuana, offering the benefits of reduced analysis time and lower costs. However, these assays were unable to distinguish hemp seeds from marijuana or provide CBD information of the sample. In summary, this presentation showcases the extensive findings from the custom-target NGS panel, leading to the development of two robust, rapid genotyping assays. The comprehensive evaluation of synthase genes enhances researchers’ understanding of the diversity within and between Cannabis sativa crop types. This research offers valuable insights for forensic science and law enforcement in their efforts to accurately differentiate hemp and marijuana varieties.
more »
« less
Development of a Next Generation Sequencing Panel Targeting Cannabinoid Synthase Genes to Distinguish Between Marijuana and Hemp
Cannabis sativa, which can be grown as marijuana or hemp, has been one of the most contentious plants in the US. Law enforcement is now tasked with identifying the two types of crops as a result of the 2018 Agricultural Improvement Act, which legalized hemp. Genetic markers are desirable for determining crop type in sample types that are inconducive to chemical analysis, such as trace residues, small leaf fragments, immature crops, aged samples, seeds, and root material. Cannabinoid synthase genes are considered the key enzymes that determine the chemical composition or chemotype of a particular cultivar. Several researchers have suggested the use of cannabinoid synthase genes, particularly tetrahydrocannabinolic acid synthase (THCAS) and cannabidiolic acid synthase (CBDAS), to forecast the chemotype of Cannabis sativa. A wider range of cannabis types must be taken into account when evaluating cannabis-related genetic markers because existing techniques for crop type identification based on previous theories may lack specificity and precision. The cannabis genome has been revealed to include several copies of cannabinoid synthase genes. The majority of homologs are pseudogenes with nucleotide identities between 91 and 95 percent to the functioning synthase genes. Therefore, the risk of amplification of pseudogenes cannot be overlooked in all synthase-gene targeting methods for the genetic testing of cannabis. This study evaluated not only THCAS and CBDAS but also synthase-like genes (pseudogenes), as well as another commonly seen synthase gene, cannabichromene acid synthase (CBCAS). A custom next generation sequencing (NGS) panel was developed that allowed us to target the three cannabinoid synthase genes: THCAS, CBDAS, and CBCAS, as well as the pseudo synthase genes: THCAS-Like, CBDAS-Like, and CBCAS-Like, in a broad variety of C. sativa samples. Samples including reference C. sativa samples from the National Institute on Drug Abuse (NIDA) and National Institute of Standards and Technology (NIST), CBD, CBG, delta-8-THC, delta-10-THC, THCO, and CBDV hemp samples, hemp seed samples, and seized marijuana extracts from the Drug Enforcement Agency (DEA). This presentation will be demonstrating the development and analysis process using the NGS panel to discover novel polymorphisms and comprehensively evaluate the relationship between the cannabis chemotype and the synthase gene copies. The study suggested a novel flow chart for genetic distinction between hemp and marijuana. The knowledge gained from this study will also be incorporated to develop a fast-genotyping assay that could potentially assist law enforcement agencies in distinguish legal hemp and illicit marijuana.
more »
« less
- Award ID(s):
- 2311009
- PAR ID:
- 10692610
- Publisher / Repository:
- Proceedings of the Association of Forensic DNA Analysts and Administrators (2023)
- Date Published:
- Subject(s) / Keyword(s):
- Cannabis sativa, Cannabinoid synthase gene, Next generation sequencing
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
Genetic markers are desirable for determining crop type in sample types that are inconducive to chemical analysis, such as trace residues, small leaf fragments, immature crops, aged samples, seeds, and root material. Cannabinoid synthase genes are considered the key enzymes that determine the chemical composition or chemotype of a particular cultivar. The use of cannabinoid synthase genes, specifically Tetrahydrocannabinolic Acid Synthase (THCAS) and Cannabidiolic Acid Synthase (CBDAS), to predict the chemotype of C. sativa has been proposed in several studies. However, existing methods for crop type differentiation based on past theory could lack specificity and precision, and a wider range of cannabis varieties must be considered when examining cannabis-based genetic markers. The success of cannabis genome assemblies has broadened our knowledge of cannabinoid synthase genes, which are found to be highly repetitive in the cannabis genome. Most homologs were pseudogenes consisting of incomplete coding sequences or contained stop codons in the reading frame, and their sequences can have 91–95% nucleotide identity to the functional synthase genes. Thus, the risk of amplification of pseudogenes cannot be overlooked in all synthase-gene targeting methods for genetic testing of cannabis. Furthermore, targeting only active THCAS or active CBDAS genes, the unique genotypes of some samples may have been missed by conventional methods. Therefore, the targets of this study also include another commonly seen synthase gene, Cannabichromene Acid Synthase (CBCAS), and the synthaselike genes (pseudogenes) with an expanded sample variety that can not only improve the identification method but also provide more information about the relationship between chemotype and synthase gene copies. A custom NGS panel was developed that allowed us to target all synthase genes (THCAS, CBDAS, and CBCAS) and tease out the amplification of pseudogenes. Additionally, with targeted sequencing, NGS platforms can also sequence a high throughput of samples. In this study, a variety of sample types were included, including reference C. sativa samples from the National Institute on Drug Abuse (NIDA) and the National Institute of Standards and Technology (NIST), CBD and CBG hemp samples from the United States and Canada, and marijuana samples from the United States–Mexico, Chile, and around the United States. Novel polymorphisms, mostly SNPs, were found between the different sample types, and the observed polymorphisms may also be related to the biogeographical origin of the plant. The results also demonstrated that the presence or absence of pseudogenes may potentially be related to the cannabinoid content in the cannabis plant. This study also discovered several synthase-like gene sequences that have not been reported before and can assist in the expansion of the database of synthase genes and pseudogenes. Overall, this presentation highlights the usage of the custom targeted NGS panel that serves as a comprehensive analysis of the three synthase genes and their pseudogenes to discover novel polymorphisms between crop types and/or strains, and the relationship between chemotype and gene copies. The large-scale evaluation of synthase genes in this study can help researchers understand the variety both within and between crop types.more » « less
-
The legalization of hemp cultivation in the United States has raised the need for reliable methods to distinguish between legal hemp and illegal marijuana. Genetic analysis has emerged as a powerful tool, surpassing traditional chemical methods in specific aspects, such as analyzing trace amounts, aged samples, and different parts of the sample. Genetic differences in cannabinoid synthase genes offer promise for precise crop type determination, particularly focusing on genes like tetrahydrocannabinolic acid synthase (THCAS), cannabidiolic acid synthase (CBDAS), and cannabichromenic acid synthase (CBCAS). However, previous research faced several challenges in developing discriminatory genetic markers, including limited sample sizes, high similarity between the synthase genes, and the presence of pseudo synthase genes. A comprehensive study using Next‐Generation Sequencing (NGS) introduced a differentiation flowchart based on THCAS, CBDAS, and THCAS pseudogenes. To bridge the gap between NGS and the practical requirements of crime laboratories, two rapid genotyping assays were developed: a CE‐based SNaPshot™ assay and a TaqMan™ real‐time PCR assay. While the SNaPshot™ assay effectively differentiated various hemp and marijuana types, differentiation was limited with marijuana samples containing THC% close to the 0.3% legal threshold (0.3%–1%). The TaqMan™ qPCR SNP genotyping assay provided quicker results, making it an efficient choice for crime laboratories. However, this method had the same limitations as the SNaPshot™ assay with addtional challenges in differentiating edible hemp seed samples, and it did not provide additional CBD information. The study also highlighted the influence of two variants of one THCAS pseudogene on chemotype determination, emphasizing the necessity for precise genetic analysis for accurate categorization of cannabis varieties.more » « less
-
Hemp and marijuana, both derived fromCannabis sativaL. (C. sativa), are subject to divergent legal regulations due to their different Δ9‐tetrahydrocannabinol (Δ9‐THC) contents. Cannabinoid synthase genes are considered the key enzymes that determine the chemical composition or chemotype of a particular cultivar. However, existing methods for crop type differentiation based on previous synthase gene theories have limitations in terms of precision and specificity, and a wider range of cannabis varieties must be considered when examining cannabis‐based genetic markers. A custom next‐generation sequencing (NGS) panel was developed targeting all synthase genes, including Δ9‐THC acid synthase, cannabidiolic acid synthase, and cannabichromenic acid synthase, as well as the pseudogenes across diverseC. sativasamples, spanning reference hemp and marijuana, commercial hemp derivatives, and seized marijuana extracts. Interpretation of NGS data revealed a relationship between genotypes and underlying chemotypes, with the principal component analysis indicating a clear distinction between hemp and marijuana clusters. This differentiation was attributed to variations in both synthase genes and pseudogene variants. Finally, this study proposes a genetic cannabis classification method using a differentiation flow chart with novel synthase markers. The flow chart successfully differentiated hemp from marijuana with a 1.3% error rate (n = 147).more » « less
-
Cannabis sativa can be cultivated as hemp or marijuana. The passage of the 2018 Federal Farm Bill legalized hemp tasks law enforcement with differentiating the two crop types. Genetic markers are desirable for determining crop type in sample types inconducive to chemical analysis, such as trace residues, immature crops, aged samples, seeds, and root material. Cannabinoid synthase genes are considered key enzymes that determine the chemical composition (chemotype) of cannabis plants. The use of genetic markers of cannabinoid synthase genes to predict chemotypes has been proposed. This study re-evaluated a previously published method and highlighted the limitation of existing markers for differentiating marijuana and hemp. This study also performed chemical analysis on hemp and reference samples to better understand the relationship between chemotype and genotype. Moreover, this study sought to develop more robust genetic markers by designing an NGS custom panel targeting three cannabinoid synthase genes to comprehensively analyze a broader range of cannabis varieties. This study demonstrated the applicability of using a high throughput sequencing technique to identify novel polymorphisms between crop types and/or strains.more » « less
An official website of the United States government

